Herbal Medicine: Friend or Foe?

Overview

Journal J Adv Pract Oncol

Date 2022 Jun 6

PMID 35663180

Authors

Roberta Bourgon

Affiliations

Soon will be listed here.

Abstract

Many cancer patients report the use of supplements and herbal medicines but may not always disclose their use to their health-care team. Along with potential interactions, these therapies may also affect outcomes of treatment. During JADPRO Live Virtual 2021, Roberta Bourgon, ND, emphasized the importance of opening a dialogue with patients regarding complementary and alternative medicine and guiding patients in making appropriate choices in their treatment.

References

Wanwimolruk S, Prachayasittikul V . Cytochrome P450 enzyme mediated herbal drug interactions (Part 1). EXCLI J. 2015; 13:347-91. PMC: 4463967. View

Eliza W, Fai C, Chung L . Efficacy of Yun Zhi (Coriolus versicolor) on survival in cancer patients: systematic review and meta-analysis. Recent Pat Inflamm Allergy Drug Discov. 2011; 6(1):78-87. DOI: 10.2174/187221312798889310. View

Yuan C, Sato K, Hollis B, Zhang S, Niedzwiecki D, Ou F . Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 2019; 25(24):7497-7505. PMC: 6911644. DOI: 10.1158/1078-0432.CCR-19-0877. View

Ghoreishi Z, Esfahani A, Djazayeri A, Djalali M, Golestan B, Ayromlou H . Omega-3 fatty acids are protective against paclitaxel-induced peripheral neuropathy: a randomized double-blind placebo controlled trial. BMC Cancer. 2012; 12:355. PMC: 3459710. DOI: 10.1186/1471-2407-12-355. View

Seely D, Wu P, Fritz H, Kennedy D, Tsui T, Seely A . Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials. Integr Cancer Ther. 2011; 11(4):293-303. DOI: 10.1177/1534735411425484. View

Michael M, Brittain M, Nagai J, Feld R, Hedley D, Oza A . Phase II study of activated charcoal to prevent irinotecan-induced diarrhea. J Clin Oncol. 2004; 22(21):4410-7. DOI: 10.1200/JCO.2004.11.125. View

Berretta M, Della Pepa C, Tralongo P, Fulvi A, Martellotta F, Lleshi A . Use of Complementary and Alternative Medicine (CAM) in cancer patients: An Italian multicenter survey. Oncotarget. 2017; 8(15):24401-24414. PMC: 5421857. DOI: 10.18632/oncotarget.14224. View

Harris E, Cao S, Littlefield B, Craycroft J, Scholten R, Kaptchuk T . Heavy metal and pesticide content in commonly prescribed individual raw Chinese Herbal Medicines. Sci Total Environ. 2011; 409(20):4297-305. PMC: 3163780. DOI: 10.1016/j.scitotenv.2011.07.032. View

Meijerman I, Beijnen J, Schellens J . Herb-drug interactions in oncology: focus on mechanisms of induction. Oncologist. 2006; 11(7):742-52. DOI: 10.1634/theoncologist.11-7-742. View

10.

Abe K, Uwagawa T, Haruki K, Takano Y, Onda S, Sakamoto T . Effects of ω-3 Fatty Acid Supplementation in Patients with Bile Duct or Pancreatic Cancer Undergoing Chemotherapy. Anticancer Res. 2018; 38(4):2369-2375. DOI: 10.21873/anticanres.12485. View

11.

Nahleh Z, Pruemer J, Lafollette J, Sweany S . Melatonin, a promising role in taxane-related neuropathy. Clin Med Insights Oncol. 2010; 4:35-41. PMC: 2883241. DOI: 10.4137/cmo.s4132. View

12.

Conklin K . Coenzyme q10 for prevention of anthracycline-induced cardiotoxicity. Integr Cancer Ther. 2005; 4(2):110-30. DOI: 10.1177/1534735405276191. View

13.

Pastorelli D, Fabricio A, Giovanis P, DIppolito S, Fiduccia P, Solda C . Phytosome complex of curcumin as complementary therapy of advanced pancreatic cancer improves safety and efficacy of gemcitabine: Results of a prospective phase II trial. Pharmacol Res. 2018; 132:72-79. DOI: 10.1016/j.phrs.2018.03.013. View

14.

Izzo A . Interactions between herbs and conventional drugs: overview of the clinical data. Med Princ Pract. 2012; 21(5):404-28. DOI: 10.1159/000334488. View

15.

Chow H, Garland L, Hsu C, Vining D, Chew W, Miller J . Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prev Res (Phila). 2010; 3(9):1168-75. PMC: 2933312. DOI: 10.1158/1940-6207.CAPR-09-0155. View

16.

Frye R, Fitzgerald S, Lagattuta T, Hruska M, Egorin M . Effect of St John's wort on imatinib mesylate pharmacokinetics. Clin Pharmacol Ther. 2004; 76(4):323-9. DOI: 10.1016/j.clpt.2004.06.007. View

17.

Hakkola J, Hukkanen J, Turpeinen M, Pelkonen O . Inhibition and induction of CYP enzymes in humans: an update. Arch Toxicol. 2020; 94(11):3671-3722. PMC: 7603454. DOI: 10.1007/s00204-020-02936-7. View

18.

Wanwimolruk S, Phopin K, Prachayasittikul V . Cytochrome P450 enzyme mediated herbal drug interactions (Part 2). EXCLI J. 2015; 13:869-96. PMC: 4464477. View

19.

Sayles C, Hickerson S, Bhat R, Hall J, Garey K, Trivedi M . Oral Glutamine in Preventing Treatment-Related Mucositis in Adult Patients With Cancer: A Systematic Review. Nutr Clin Pract. 2015; 31(2):171-9. DOI: 10.1177/0884533615611857. View

20.

Wang W, Lin J, Lin T, Chen W, Jiang J, Wang H . Oral glutamine is effective for preventing oxaliplatin-induced neuropathy in colorectal cancer patients. Oncologist. 2007; 12(3):312-9. DOI: 10.1634/theoncologist.12-3-312. View